Published in Tuberculosis (Edinb) on June 02, 2012
The next 10 years for tuberculosis vaccines: do we have the right plans in place? Expert Rev Vaccines (2013) 0.90
Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality. Am J Respir Cell Mol Biol (2015) 0.79
Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy. Front Immunol (2017) 0.75
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis (2012) 4.60
A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med (2007) 4.07
Paediatric tuberculosis. Lancet Infect Dis (2008) 3.97
Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 2.90
Immunological biomarkers of tuberculosis. Nat Rev Immunol (2011) 2.88
IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol (2007) 2.75
The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J (2011) 2.47
Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest (2007) 2.38
Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med (2012) 2.32
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ (2008) 2.17
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest (2011) 1.89
A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A (2006) 1.64
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South Africa. Bull World Health Organ (2009) 1.62
Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis (2002) 1.59
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. Tuberculosis (Edinb) (2013) 1.34
Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One (2008) 1.32
Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med (2012) 1.30
Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child (2009) 1.29
Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol (2002) 1.29
Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting. BMC Med Ethics (2008) 1.27
Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science (2006) 1.27
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology (2009) 1.21
Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One (2012) 1.19
Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy (2007) 1.17
Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. J Infect Dis (2011) 1.17
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol (2013) 1.12
Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J (2012) 1.11
Childhood tuberculosis: old and new vaccines. Paediatr Respir Rev (2007) 1.10
Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis. Pediatr Infect Dis J (2014) 1.08
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol (2013) 1.07
Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. J Infect Dis (2011) 1.06
CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med (2010) 1.04
Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function. J Infect Dis (2003) 1.01
Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis (2013) 1.01
Childhood tuberculosis: out of sight, out of mind? Trans R Soc Trop Med Hyg (2007) 1.00
Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis. Clin Dev Immunol (2012) 1.00
Paediatric emergency care in resource-limited settings. Lancet (2013) 0.99
Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine. Antimicrob Agents Chemother (2012) 0.99
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J (2012) 0.99
Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J (2015) 0.98
Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis (2012) 0.98
The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun (2013) 0.98
HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. Eur J Immunol (2012) 0.97
Early deaths during tuberculosis treatment are associated with depressed innate responses, bacterial infection, and tuberculosis progression. J Infect Dis (2011) 0.96
Immunology and pathogenesis of childhood TB. Paediatr Respir Rev (2010) 0.96
Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS (2014) 0.96
Soluble ecto-5'-nucleotidase (5'-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem (2013) 0.95
Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev (2008) 0.95
Enhanced anti-mycobacterial immunity in children with erythema nodosum and a positive tuberculin skin test. J Invest Dermatol (2007) 0.94
Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa. PLoS One (2013) 0.94
Time to symptom resolution in young children treated for pulmonary tuberculosis. Pediatr Infect Dis J (2014) 0.92
Achieving comprehensive childhood immunization: an analysis of obstacles and opportunities in The Gambia. Health Policy Plan (2013) 0.92
The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS (2015) 0.91
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin Vaccine Immunol (2006) 0.90
Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation. Infect Immun (2011) 0.90
Detection and treatment of subclinical tuberculosis. Tuberculosis (Edinb) (2012) 0.89
Blood tests for diagnosis of tuberculosis. Lancet (2006) 0.89
Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women. J Immunol Methods (2010) 0.89
Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS One (2006) 0.89
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest (2015) 0.89
Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia. Emerg Infect Dis (2013) 0.88
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trials. Vaccine (2011) 0.87
How to use: interferon γ release assays for tuberculosis. Arch Dis Child Educ Pract Ed (2013) 0.86
Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation. Am J Trop Med Hyg (2014) 0.86
Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol (2007) 0.85
Knowledge and acceptability of patient-specific infection control measures for pulmonary tuberculosis. Am J Infect Control (2013) 0.84
Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. Thorax (2012) 0.84
Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa. Trop Med Int Health (2013) 0.83
DosS Is required for the complete virulence of mycobacterium tuberculosis in mice with classical granulomatous lesions. Am J Respir Cell Mol Biol (2015) 0.83
Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients. Eur J Immunol (2014) 0.83
Neonatal admissions, quality of care and outcome: 4 years of inpatient audit data from The Gambia's teaching hospital. Paediatr Int Child Health (2015) 0.83
Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open (2013) 0.82
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest (2015) 0.82
Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis (2013) 0.82
A functional whole blood assay to measure viability of mycobacteria, using reporter-gene tagged BCG or M.Tb (BCGlux/M.Tb lux). J Vis Exp (2011) 0.81
Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. J Immunol (2014) 0.81
Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers. Vaccine (2010) 0.80
Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis. BMC Infect Dis (2014) 0.80
Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013. Pediatr Infect Dis J (2015) 0.79
Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom. Pediatr Infect Dis J (2013) 0.79
Bridging the gap: maternal immunisation as a means to reduce neonatal deaths from infectious diseases. Pathog Glob Health (2012) 0.78
Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial setting. Pediatr Infect Dis J (2012) 0.78
Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosis. PLoS One (2009) 0.78
Vaccine-induced immunity in early life. Vaccine (2013) 0.77
Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants. AIDS (2016) 0.76
Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia. Clin Infect Dis (2013) 0.76
Kawasaki disease coincident with influenza A H1N1/09 infection. Pediatr Int (2011) 0.76
Multidrug-resistant tuberculosis in UK children: presentation, management and outcome. Eur Respir J (2013) 0.75
Impact of immigration on pulmonary tuberculosis in spanish children. Pediatr Infect Dis J (2010) 0.75
Serologic Responses in Childhood Pulmonary Tuberculosis. Pediatr Infect Dis J (2017) 0.75
Bacterial genomics and vaccine design. Expert Rev Vaccines (2003) 0.75